Settle and National Disability Insurance Agency

Link copied
Case Copied 35 min read

Settle and National Disability Insurance Agency [2024] AATA 1343 (3 June 2024)

Division:NATIONAL DISABILITY INSURANCE SCHEME DIVISION

File Number:          2021/9786

Re:Kim Settle  

APPLICANT

AndNational Disability Insurance Agency

RESPONDENT

DECISION

Tribunal:Member S Smith

Date:3 June 2024

Place:Brisbane

Pursuant to section 43(1)(a) of the Administrative Appeals Tribunal Act 1975 (Cth), the Tribunal affirms the decision under review not to grant the applicant access to the National Disability Insurance Scheme on the basis that the applicant does not meet either the ‘disability requirements’ under section 24 or the ‘early intervention requirements’ under section 25 of the National Disability Insurance Scheme Act 2013 (Cth).

........................[SGD].........................

Member S Smith

Catchwords

NATIONAL DISABILITY INSURANCE SCHEME – request for access – chronic fatigue syndrome - fibromyalgia – irritable bowel syndrome – chemical sensitivity - whether the effects of an impairment are permanent - whether there are known, available and appropriate treatments likely to remedy an impairment – available treatment - whether further investigations are required to determine permanency of impairments – degree of severity and permanency of impairments – decision under review affirmed.

Legislation

Administrative Appeals Tribunal Act 1975 (Cth)
National Disability Insurance Scheme Act2013 (Cth)
National Disability Insurance Scheme (Becoming a Participant) Rules 2016

Cases

Mulligan v National Disability Insurance Agency [2015] FCA 544

National Disability Insurance Agency v Davis [2022] FCA 1002 
National Disability Insurance Scheme v Foster [2023] FCAFC 11
Re Schwass and National Disability Insurance Agency [2019] AATA 28

Secondary Materials

National Disability Insurance Scheme - Operational Guidelines – Access (updated 01 February 2024)

REASONS FOR DECISION

Member S Smith

3 June 2024

INTRODUCTION

  1. Ms Kim Settle is 59 years old and resides in North Queensland. She lives with her elderly mother, aged 86 years who is her primary informal carer. She is currently a performing musician and has previously worked as a teacher of physical education.

  2. In 1996 while working at a primary school Ms Settle was exposed to chemicals from carpet glue[1] and she thereafter began to experience debilitating physical symptoms.[2]

    [1] T Documents: T14: Letter of Dr Stacey Waugh dated 20 May 2021, page 49.

    [2] T Documents, T18: Statement of Ms Settle, undated, page 66.

  3. In 2009 Ms Settle ceased employment as a teacher and came into receipt of the Disability Support Pension.[3]

    [3] T Documents, T4: Letter, Principal Claims Manager dated 27 July 2009.

  4. On 6 July 2021 Ms Settle made a verbal access request to the National Disability Insurance Agency (the Agency) for access to the National Disability Insurance Scheme (the scheme).[4] 

    [4] Email from the Agency to the Tribunal dated 13 May 2024.

  5. On 17 August 2021 the Agency refused Ms Settle access on the basis that she was unable to meet the statutory access criteria. Ms Settle subsequently applied for an internal review of that decision.[5]

    [5] T Documents, T16: Interaction Notes dated 8 October 2021.

  6. On 22 November 2021 Ms Settle was notified that, under section 100(6) of the National Disability Insurance Scheme Act

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Settle and National Disability Insurance Agency and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2024] AATA 1343
Decision Date

CaseChat Overview and Summary

This matter concerned an application for access to the National Disability Insurance Scheme (NDIS) by Ms Settle, who sought to establish that she met the disability requirements under the NDIS Act 2013 (Cth). The National Disability Insurance Agency (NDIA) had made a decision to refuse access, which Ms Settle sought to have reviewed by the Tribunal. Ms Settle's application was based on a range of conditions including chronic fatigue syndrome (CFS), fibromyalgia, irritable bowel syndrome (IBS), chemical sensitivity, Graves' disease, and hyperthyroidism.

The Tribunal was required to determine whether Ms Settle had a disability attributable to physical and psychosocial impairments, and whether these impairments were permanent or likely to be permanent. Specifically, the court had to consider if there were known, available, and appropriate treatments likely to remedy the impairments, and whether further investigations were required to determine the permanency of these impairments. The assessment of permanency also involved considering the degree of severity and the enduring nature of the impairments, necessitating ongoing supports.

In its reasoning, the Tribunal found that Ms Settle had established impairments of CFS and fibromyalgia, accepting the uncontested evidence of Dr Parkes regarding her diagnoses and the constellation of symptoms arising from central sensitisation syndrome. However, the Tribunal was not satisfied that Ms Settle had adequately substantiated a diagnosis of IBS, Graves' disease, or hyperthyroidism to the required degree of precision for the purposes of the NDIS Act. Regarding permanency, the Tribunal considered the definition of an "available treatment" and the meaning of "remedy" as a cure or removal of an impairment. The Tribunal noted that an impairment is permanent if it has an enduring nature and requires ongoing supports, and that permanency is only demonstrated if no further medical treatment or review is required.

The Tribunal affirmed the NDIA's decision, concluding that while Ms Settle had established certain impairments, she had not satisfied the requirements for permanency under the NDIS Act. The Tribunal was not satisfied that the impairments were permanent or likely to be permanent, nor that there were no known, available, and evidence-based treatments likely to remedy them, nor that no further medical treatment or review was required to demonstrate their permanency.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

The question of whether Ms Settle meets the legislative requirements is a question of fact that must be determined on the balance of the available evidence. The Tribunal must undertake a precise ‘fact finding task’[15] and be positively satisfied[16] that Ms Settle meets either the disability requirements, or the early intervention requirements. EVIDENCE[15] National Disability Insurance Agency v Davis [2022] FCA 1002 (Davis) at [42].[16] Mulligan at [55]; also cited in Re Schwass and NDIA [2019] AATA at [29] and Davis [at 61].Dr Stephen Rudolphy Ms Settle stated that Dr Stephen Rudolphy initially diagnosed with her with IBS in 1999, CFS in 2006 and then fibromyalgia in 2009. The reports or letters produced by Dr Rudolphy have not been provided to the Tribunal and are only referred to in other evidence.[17] [17] T Documents, T3: Dr Parkes reviewed two letters of Dr Rudolphy dated 1 May 1997 and 1 June 1997; also two reports of Dr Rudolphy dated 1 July 2006 and 24 April 2009. T7: Dr Sue Cory stated that CFS was diagnosed in 1999 by Dr Rudolphy. Other evidence was tendered by Ms Settle that has referred to Dr Rudolphy’s letters and reports although state that Dr Rudolphy diagnosed Ms Settle with CFS in 1999 and fibromyalgia in 2009.Dr Robert Parkes On 18 June 2009 Dr Robert Parkes, general physician assessed Ms Settle in person and produced a report dated 3 July 2009 for the purpose of providing an independent opinion of Ms Settle’s capacity to return to work in the context of her insurance claim arising from her workplace injury.[18] [18] T Documents, T3: Report of Dr Robert Parkes dated 3 July 2009. Dr Parkes did not personally examine Ms Settle, in particular because he was satisfied that she had already undergone careful assessment by a number of general and specialist practitioners. Based on his interview Dr Parkes considered that the main condition preventing Ms Settle from working was a combination of CFS and fibromyalgia. Ms Settle reported principal symptoms of pain ‘all over’, feelings of pins and needles in the body and particularly on exertion, extreme fatigue, abdominal pain with episodic bloating and diarrhoea, infertility coupled with dysmenorrhoea, episodic pounding headaches with hypersensitivity to light and noise consistent with migraine, a feeling of burning in her retrosternal area associated with cough, nocturia, a feeling of discomfort in her right lower chest described as being ‘like fluid in my lungs’, undue sensitivity to inhalants in particular tobacco smoke and perfume and significant exhaustion. Dr Parkes’ conclusion was that Ms Settle has been exposed to xylene and isocyanates, two chemicals present in carpet glue and both of which may cause asthma. He stated that Ms Settle had gone on to develop a ‘constellation of symptoms’ of IBS, migraine, fibromyalgia, CFS and hypersensitivity to environmental chemicals including tobacco and perfume. Dr Parkes provided a diagnosis of central sensitisation syndrome which was explained as a group of conditions where patients have physical and emotional symptoms that are disabling but physical signs are lacking.

Decision

Reasons for decision

I am not satisfied that Ms Settle has agitated an impairment of Graves’ disease or hyperthyroidism in her application.Section 24(1)(a): Conclusion I am satisfied that Ms Settle has a disability attributable to the impairments of chronic fatigue syndrome and fibromyalgia. I accept the uncontested evidence of Dr Parkes that Ms Settle has been diagnosed with CFS and fibromyalgia and also that she experiences a ‘constellation of symptoms’ as a result of a central sensitisation syndrome. An impairment is generally understood to mean ‘the loss of or damage to a physical, sensory or mental function.’[55] The assessment of impairments is ‘functional and multi-faceted’ and requires a relatively high degree of precision.[56][55] Mulligan v National Disability Insurance Agency [2015] FCA 544 (Mulligan) at [51].[56] Mulligan at [55] The symptoms that Ms Settle submits are as a result of her other conditions of IBS, chemical sensitivity, Graves’ disease and hyperthyroidism have not been distinguished as impairments to a satisfactory degree of precision that is required under section 24(1)(a) and section 25(1)(a). Section 24(1)(b): Permanency The Tribunal considers whether Ms Settle’s impairments of CFS and fibromyalgia are or are likely to be ‘permanent’ and whether, on the evidence before it:(a)there are no known, available and evidence-based treatments likely to remedy the impairments; and(b)no further medical treatment or review is required for their permanency or likely permanency to be demonstrated. An ‘available treatment’ contemplates treatment available to a particular individual including their financial capacity to access a treatment.[57][57] See National Disability Insurance Agency v Davis [2022] FCA 1002 at [138]. To ‘remedy’ should be understood to mean something approaching a removal or cure of an impairment.[58] [58] Ibid at [136]. ‘Permanency’ should be understood to mean that the impairments that Ms Settle experiences have an enduring nature and require supports provided and/or funded under the scheme on an ongoing basis.[59][59] Ibid at [130]. Rule 5.6 of the access rules states:An impairment may require medical treatment and review before a determination can be made about whether the impairment is permanent or likely to be permanent. The impairment is, or is likely to be, permanent only if the impairment does not require further medical treatment or review in order for its permanency or likely permanency to be demonstrated. The Tribunal further contemplates the meaning of the ‘permanency’ of an impairment in the decision of Mulligan v National Disability Insurance Agency:[60]‘Although an impairment may…be responsible for or related to a disability, the threshold in s 24 revolves around the severity and permanency of the effects of the impairments experienced by a person, so as to justify the provision of the “reasonable and necessary supports” to which participants may be entitled…’(Tribunal emphasis)[60] [2015] FCA 544 (Mulligan) at [52].

Ratio Decidendi

Legal Principle Established

Ms Settle stated:‘In conclusion, after many years of living with these debilitating disabilities and trying everything possible to get better I know it is permanent. I also know that if I can maintain my health by eating a healthy diet with small amounts of exercise and if I can keep doing my hobby job, I will be able to keep my major breakdowns to a minimum. However, I do not have the help I need to be able to do this. Mum is not able to do as much as she did before, and I am already feeling it and having more crashes, I need extra help now. …Also, I will always be exposed to people who wear deodorant or perfumes etc at some stage in the day week month and at times there will always be some sort of smoke or chemical smell around and I also cannot control the weather.’CONSIDERATIONSection 24: the Disability Requirements24(1)(a): Disability attributable to physical and psychosocial impairmentsChronic fatigue syndrome and fibromyalgia The evidence has established that Ms Settle has impairments of chronic fatigue syndrome and fibromyalgia. The reports of Dr Rudolphy who made these diagnoses have not been provided in evidence for the Tribunal to consider. Dr Parkes, who was provided these reports, in his own report referred to Ms Settle’s ‘clinical diagnosis’ of CFS.[49] Dr Parkes also supported a diagnosis of CFS for Ms Settle.[50][49] T Documents, T3, page 20.[50] T Documents, T3, page 23. Likewise, Dr Parkes and Dr Cory have accepted Dr Rudolphy’s diagnosis of fibromyalgia and Dr Parkes also supported a diagnosis of fibromyalgia in his own report. Irritable bowel syndrome On the evidence I am not satisfied that Ms Settle has an impairment of irritable bowel syndrome. Ms Settle’s evidence was that she had been diagnosed with IBS by Dr Rudolphy in 2009. This statement is not substantiated in any other evidence before the Tribunal. In 2015 Dr Guraratbakul’s report was that Ms Settle’s abdominal pain ‘most likely sounds like functional irritable bowel syndrome to us’. In the absence of any further context or evidence relevant to supporting a diagnosis of IBS, this statement is not considered in itself a satisfactory diagnosis for the purposes of establishing a disability under section 24(1)(a). Ms Settle obtained further reports from the Dietetics/Nutrition team, one of which stated that Ms Settle had a diagnosis of ‘IBS-type gastrointestinal symptoms with multiple other health problems and anxiety’.[51] [51] T Documents, T9, page 35. This diagnosis is most consistent with the evidence of Dr Parkes who stated that IBS and hypersensitivity were amongst the ‘constellation of symptoms’ that Ms Settle experienced as a result of a central sensitisation syndrome (CSS). I consider this evidence uncontested and accept that Ms Settle experiences IBS-type symptoms. Dr Waugh’s evidence was that Ms Settle became a recipient of the DSP in 2007 based on a diagnosis of Fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome.